Loading
Latest filing published 02 Jan 2013 for ProUroCare Medical Inc., €5,357.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Michael Chambers discloses dealings in ProUroCare Medical Inc. to SEC (Form 4). Over a trading history stretching from 1 July 2010 to 28 December 2012, the count stands at 10 filings.
Purchases make up the whole of the open-market record (1 purchase, €4,243). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 7 share grants and 2 option exercises.
On 2 January 2013 came the latest disclosure, a share grant for €4,528 in ProUroCare Medical Inc. The latest purchase dates back some time: it was published 5,953 days ago, on 7 July 2010. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations